Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

New Approaches in Evaluating Patients Response to Botulinum Toxins in the Treatment of Chronic Neck Pain and Back Pain

Trial Profile

New Approaches in Evaluating Patients Response to Botulinum Toxins in the Treatment of Chronic Neck Pain and Back Pain

Status: Recruiting
Phase of Trial: Phase I

Latest Information Update: 11 Dec 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Botulinum toxin B (Primary) ; Botulinum-Toxin-A (Primary)
  • Indications Back pain; Musculoskeletal pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Dec 2017 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
    • 05 Dec 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Aug 2018.
    • 31 Oct 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top